<乌鸦传媒>And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetes Established weight loss and diabetes drug may extend reach to millions more Nov 11, 2023
<乌鸦传媒>Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<乌鸦传媒>Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? News and commentary from the endocrinology world Nov 07, 2023
<乌鸦传媒>Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<乌鸦传媒>Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer News and commentary from the endocrinology world Oct 31, 2023
<乌鸦传媒>Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? News and commentary from the endocrinology world Oct 24, 2023
<乌鸦传媒>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<乌鸦传媒>Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kids These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
<乌鸦传媒>Obesity Medication Type, Insurance Carrier Linked to Treatment Persistence Amount of weight lost by 6 months also played a role, according to a retrospective cohort study Oct 18, 2023
<乌鸦传媒>Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Study At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months Oct 17, 2023
<乌鸦传媒>Certain Factors Predict Weight Regain After Big Losses But even "regainers" still kept off most of the weight Oct 17, 2023
<乌鸦传媒>Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortality Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
<乌鸦传媒>Semaglutide's Weight-Loss Benefit Also Seen in Patients on Antidepressants Those on antidepressants lost an average 11% to 19% of body weight across the four STEP trials Oct 16, 2023
<乌鸦传媒>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<乌鸦传媒>Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risks Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
<乌鸦传媒>Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test News and commentary from the endocrinology world Oct 10, 2023
<乌鸦传媒>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<乌鸦传媒>Weight-Loss Drug Benefit Spans HFpEF, HFmrEF STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
<乌鸦传媒>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<乌鸦传媒>Are Obesity Drugs for Adolescents Cost-Effective? Despite the effectiveness of these medications, costs are a major barrier Sep 30, 2023
<乌鸦传媒>MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraising 乌鸦传媒 reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
<乌鸦传媒>FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<乌鸦传媒>Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
<乌鸦传媒>The GLP-1 Agonist Plateau No One's Talking About Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
<乌鸦传媒>Over One-Third of Adults in 22 States Have Obesity, CDC Says No states hit this threshold a decade ago Sep 22, 2023
<乌鸦传媒>Diabetes in Night Owls; 'Paradigm-Shifting' Drugs; Transgender Trials Unethical? News and commentary from the endocrinology world Sep 19, 2023
<乌鸦传媒>Is Being a Night Owl Unhealthy? CRC Screening Not Recommended Enough Also in TTHealthWatch: CVD death and obesity Sep 16, 2023 podcast
<乌鸦传媒>Weight-Loss Surgery Tied to Lower Blood Cancer Risk in Women Consider surgery for primary prevention in people with obesity, researchers suggest Sep 15, 2023
<乌鸦传媒>New Weight-Loss Drugs Spark Debate About Safety During Surgery Some anesthesiologists think current guidelines don't go far enough Sep 08, 2023
<乌鸦传媒>Endocrine Disruptors in Paper Straws; Wegovy's CV Benefit; Stroke and Infertility Tx News and commentary from the endocrinology world Sep 05, 2023
<乌鸦传媒>Real-World Data Back ECMO Use in Critically Ill Patients With Obesity Obesity should not be considered a contraindication for use, say researchers Aug 30, 2023
<乌鸦传媒>Insulin Calculator Cleared; Twice-Rejected Diabetes Drug; Ozempic for Alcohol Use? News and commentary from the endocrinology world Aug 29, 2023
<乌鸦传媒>'Big Win' for Anti-Obesity Medication in Heart Failure Semaglutide led to meaningful reductions in symptoms, weight in patients with obesity and HFpEF Aug 29, 2023 video
<乌鸦传媒>Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failure Heart failure with preserved ejection fraction and obesity becoming more common Aug 25, 2023
<乌鸦传媒>Liver Concerns Foil GLP-1 Drug; Not Enough Menopause Training; Wegovy Supply Limits News and commentary from the endocrinology world Aug 15, 2023
<乌鸦传媒>Clinically Significant Weight Loss Uncommon for Most Overweight Adults Only one in 10 with overweight or obesity achieve 5% or greater weight loss each year Aug 07, 2023
<乌鸦传媒>Unexplained Heart Enlargement May Be Causing Sudden Deaths in Obesity Increased ventricular mass without the usual etiologies of heart disease was noted Jul 28, 2023
<乌鸦传媒>Trial Supports GLP-1 After Underwhelming Metabolic Surgery Helped more patients achieve clinically significant weight loss Jul 27, 2023
<乌鸦传媒>Gastric Bypass Surgery Tied to Higher Risk of Substance Use Disorder Prior findings from same cohort showed link between alcohol use disorder and bariatric surgery Jul 21, 2023
<乌鸦传媒>Aspartame Is a 'Possible' Carcinogen, WHO Declares But the organization's recommended limits on aspartame consumption remain unchanged Jul 13, 2023
